gms | German Medical Science

104. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft e. V. (DOG)

21. - 24.09.2006, Berlin

Intravitreal triamcinolone in the treatment of diabetic hard exudates

Meeting Abstract

Suche in Medline nach

  • G. Bencic - University Department of Ophthalmology, University Hospital "Sestre Milosrdnice"
  • Z. Vatavuk - University Department of Ophthalmology, University Hospital "Sestre Milosrdnice"
  • D. Grgic - University Department of Ophthalmology, University Hospital "Sestre Milosrdnice"
  • Z. Mandic - University Department of Ophthalmology, University Hospital "Sestre Milosrdnice"

Deutsche Ophthalmologische Gesellschaft e.V.. 104. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft (DOG). Berlin, 21.-24.09.2006. Düsseldorf, Köln: German Medical Science; 2006. Doc06dogSA.01.01

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/dog2006/06dog274.shtml

Veröffentlicht: 18. September 2006

© 2006 Bencic et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective

To report short-term efficacy of intravitreal triamcinolone acetonide in patients with massive hard exudates.

Methods

We enrolled 16 patients (19 eyes) with massive hard exudates involving the fovea in a prospective noncomparative interventional study. All patients received a single intravitreal injection of 4 mg of triamcinolone. We evaluated visual acuity, resolution of hard exudates and postoperative complications after the injection.

Results

After a mean follow-up time of 6.4 months average visual acuity improved from 0,05 to 0,1. Thirteen eyes had an initial visual acuity ranging from 0,0125 to 0,025. None of these eyes achieved visual acuity better than 0,075. Resolution of hard exudates was noted in all eyes, with complete resolution being noticed in 5 eyes and partial resolution in 14 eyes. Intraocular pressure elevation, requiring topical medication was noted in 4 eyes. We had no serious complications, such as endophthalmitis.

Conclusions

Triamcinolone acetonide seems to be beneficial in reducing hard exudates and improving visual acuity in diabetic patients. Further evaluation of long-term safety and efficacy of triamcinolone is warranted.